1. Home
  2. CRBU vs ELMD Comparison

CRBU vs ELMD Comparison

Compare CRBU & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$2.38

Market Cap

192.4M

Sector

Health Care

ML Signal

HOLD

Logo Electromed Inc.

ELMD

Electromed Inc.

HOLD

Current Price

$37.92

Market Cap

208.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRBU
ELMD
Founded
2011
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
192.4M
208.1M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
CRBU
ELMD
Price
$2.38
$37.92
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$10.75
$36.00
AVG Volume (30 Days)
1.6M
63.4K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
3.64
46.55
EPS
N/A
0.91
Revenue
N/A
$54,716,000.00
Revenue This Year
$1.63
$15.59
Revenue Next Year
$10.93
$11.51
P/E Ratio
N/A
$43.15
Revenue Growth
N/A
13.83
52 Week Low
$0.96
$17.73
52 Week High
$3.53
$39.65

Technical Indicators

Market Signals
Indicator
CRBU
ELMD
Relative Strength Index (RSI) 67.29 71.63
Support Level $1.75 $23.47
Resistance Level $2.97 N/A
Average True Range (ATR) 0.17 2.70
MACD 0.03 0.35
Stochastic Oscillator 90.48 87.11

Price Performance

Historical Comparison
CRBU
ELMD

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: